1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hybrid Closed-Loop lnsulin Delivery System Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Hybrid Closed-Loop lnsulin Delivery System by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Hybrid Closed-Loop lnsulin Delivery System by Country/Region, 2018, 2022 & 2029
2.2 Hybrid Closed-Loop lnsulin Delivery System Segment by Type
2.2.1 Type 1 Hybrid Closed Loop System
2.2.2 Type 2 Hybrid Closed Loop System
2.3 Hybrid Closed-Loop lnsulin Delivery System Sales by Type
2.3.1 Global Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Type (2018-2023)
2.3.2 Global Hybrid Closed-Loop lnsulin Delivery System Revenue and Market Share by Type (2018-2023)
2.3.3 Global Hybrid Closed-Loop lnsulin Delivery System Sale Price by Type (2018-2023)
2.4 Hybrid Closed-Loop lnsulin Delivery System Segment by Application
2.4.1 Hospital
2.4.2 Private
2.4.3 Others
2.5 Hybrid Closed-Loop lnsulin Delivery System Sales by Application
2.5.1 Global Hybrid Closed-Loop lnsulin Delivery System Sale Market Share by Application (2018-2023)
2.5.2 Global Hybrid Closed-Loop lnsulin Delivery System Revenue and Market Share by Application (2018-2023)
2.5.3 Global Hybrid Closed-Loop lnsulin Delivery System Sale Price by Application (2018-2023)
3 Global Hybrid Closed-Loop lnsulin Delivery System by Company
3.1 Global Hybrid Closed-Loop lnsulin Delivery System Breakdown Data by Company
3.1.1 Global Hybrid Closed-Loop lnsulin Delivery System Annual Sales by Company (2018-2023)
3.1.2 Global Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Company (2018-2023)
3.2 Global Hybrid Closed-Loop lnsulin Delivery System Annual Revenue by Company (2018-2023)
3.2.1 Global Hybrid Closed-Loop lnsulin Delivery System Revenue by Company (2018-2023)
3.2.2 Global Hybrid Closed-Loop lnsulin Delivery System Revenue Market Share by Company (2018-2023)
3.3 Global Hybrid Closed-Loop lnsulin Delivery System Sale Price by Company
3.4 Key Manufacturers Hybrid Closed-Loop lnsulin Delivery System Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hybrid Closed-Loop lnsulin Delivery System Product Location Distribution
3.4.2 Players Hybrid Closed-Loop lnsulin Delivery System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Hybrid Closed-Loop lnsulin Delivery System by Geographic Region
4.1 World Historic Hybrid Closed-Loop lnsulin Delivery System Market Size by Geographic Region (2018-2023)
4.1.1 Global Hybrid Closed-Loop lnsulin Delivery System Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Hybrid Closed-Loop lnsulin Delivery System Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Hybrid Closed-Loop lnsulin Delivery System Market Size by Country/Region (2018-2023)
4.2.1 Global Hybrid Closed-Loop lnsulin Delivery System Annual Sales by Country/Region (2018-2023)
4.2.2 Global Hybrid Closed-Loop lnsulin Delivery System Annual Revenue by Country/Region (2018-2023)
4.3 Americas Hybrid Closed-Loop lnsulin Delivery System Sales Growth
4.4 APAC Hybrid Closed-Loop lnsulin Delivery System Sales Growth
4.5 Europe Hybrid Closed-Loop lnsulin Delivery System Sales Growth
4.6 Middle East & Africa Hybrid Closed-Loop lnsulin Delivery System Sales Growth
5 Americas
5.1 Americas Hybrid Closed-Loop lnsulin Delivery System Sales by Country
5.1.1 Americas Hybrid Closed-Loop lnsulin Delivery System Sales by Country (2018-2023)
5.1.2 Americas Hybrid Closed-Loop lnsulin Delivery System Revenue by Country (2018-2023)
5.2 Americas Hybrid Closed-Loop lnsulin Delivery System Sales by Type
5.3 Americas Hybrid Closed-Loop lnsulin Delivery System Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hybrid Closed-Loop lnsulin Delivery System Sales by Region
6.1.1 APAC Hybrid Closed-Loop lnsulin Delivery System Sales by Region (2018-2023)
6.1.2 APAC Hybrid Closed-Loop lnsulin Delivery System Revenue by Region (2018-2023)
6.2 APAC Hybrid Closed-Loop lnsulin Delivery System Sales by Type
6.3 APAC Hybrid Closed-Loop lnsulin Delivery System Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Hybrid Closed-Loop lnsulin Delivery System by Country
7.1.1 Europe Hybrid Closed-Loop lnsulin Delivery System Sales by Country (2018-2023)
7.1.2 Europe Hybrid Closed-Loop lnsulin Delivery System Revenue by Country (2018-2023)
7.2 Europe Hybrid Closed-Loop lnsulin Delivery System Sales by Type
7.3 Europe Hybrid Closed-Loop lnsulin Delivery System Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Hybrid Closed-Loop lnsulin Delivery System by Country
8.1.1 Middle East & Africa Hybrid Closed-Loop lnsulin Delivery System Sales by Country (2018-2023)
8.1.2 Middle East & Africa Hybrid Closed-Loop lnsulin Delivery System Revenue by Country (2018-2023)
8.2 Middle East & Africa Hybrid Closed-Loop lnsulin Delivery System Sales by Type
8.3 Middle East & Africa Hybrid Closed-Loop lnsulin Delivery System Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hybrid Closed-Loop lnsulin Delivery System
10.3 Manufacturing Process Analysis of Hybrid Closed-Loop lnsulin Delivery System
10.4 Industry Chain Structure of Hybrid Closed-Loop lnsulin Delivery System
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hybrid Closed-Loop lnsulin Delivery System Distributors
11.3 Hybrid Closed-Loop lnsulin Delivery System Customer
12 World Forecast Review for Hybrid Closed-Loop lnsulin Delivery System by Geographic Region
12.1 Global Hybrid Closed-Loop lnsulin Delivery System Market Size Forecast by Region
12.1.1 Global Hybrid Closed-Loop lnsulin Delivery System Forecast by Region (2024-2029)
12.1.2 Global Hybrid Closed-Loop lnsulin Delivery System Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Hybrid Closed-Loop lnsulin Delivery System Forecast by Type
12.7 Global Hybrid Closed-Loop lnsulin Delivery System Forecast by Application
13 Key Players Analysis
13.1 Medtronic Inc.
13.1.1 Medtronic Inc. Company Information
13.1.2 Medtronic Inc. Hybrid Closed-Loop lnsulin Delivery System Product Portfolios and Specifications
13.1.3 Medtronic Inc. Hybrid Closed-Loop lnsulin Delivery System Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Medtronic Inc. Main Business Overview
13.1.5 Medtronic Inc. Latest Developments
13.2 Insulet Corporation
13.2.1 Insulet Corporation Company Information
13.2.2 Insulet Corporation Hybrid Closed-Loop lnsulin Delivery System Product Portfolios and Specifications
13.2.3 Insulet Corporation Hybrid Closed-Loop lnsulin Delivery System Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Insulet Corporation Main Business Overview
13.2.5 Insulet Corporation Latest Developments
13.3 Beta Bionics
13.3.1 Beta Bionics Company Information
13.3.2 Beta Bionics Hybrid Closed-Loop lnsulin Delivery System Product Portfolios and Specifications
13.3.3 Beta Bionics Hybrid Closed-Loop lnsulin Delivery System Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Beta Bionics Main Business Overview
13.3.5 Beta Bionics Latest Developments
13.4 EliLilly
13.4.1 EliLilly Company Information
13.4.2 EliLilly Hybrid Closed-Loop lnsulin Delivery System Product Portfolios and Specifications
13.4.3 EliLilly Hybrid Closed-Loop lnsulin Delivery System Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 EliLilly Main Business Overview
13.4.5 EliLilly Latest Developments
13.5 WaveForm (AgaMatrix)
13.5.1 WaveForm (AgaMatrix) Company Information
13.5.2 WaveForm (AgaMatrix) Hybrid Closed-Loop lnsulin Delivery System Product Portfolios and Specifications
13.5.3 WaveForm (AgaMatrix) Hybrid Closed-Loop lnsulin Delivery System Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 WaveForm (AgaMatrix) Main Business Overview
13.5.5 WaveForm (AgaMatrix) Latest Developments
13.6 Bigfoot Biomedical
13.6.1 Bigfoot Biomedical Company Information
13.6.2 Bigfoot Biomedical Hybrid Closed-Loop lnsulin Delivery System Product Portfolios and Specifications
13.6.3 Bigfoot Biomedical Hybrid Closed-Loop lnsulin Delivery System Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Bigfoot Biomedical Main Business Overview
13.6.5 Bigfoot Biomedical Latest Developments
13.7 Tandem Inc.
13.7.1 Tandem Inc. Company Information
13.7.2 Tandem Inc. Hybrid Closed-Loop lnsulin Delivery System Product Portfolios and Specifications
13.7.3 Tandem Inc. Hybrid Closed-Loop lnsulin Delivery System Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Tandem Inc. Main Business Overview
13.7.5 Tandem Inc. Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Hybrid Closed-Loop lnsulin Delivery System Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Hybrid Closed-Loop lnsulin Delivery System Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Type 1 Hybrid Closed Loop System
Table 4. Major Players of Type 2 Hybrid Closed Loop System
Table 5. Global Hybrid Closed-Loop lnsulin Delivery System Sales by Type (2018-2023) & (K Units)
Table 6. Global Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Type (2018-2023)
Table 7. Global Hybrid Closed-Loop lnsulin Delivery System Revenue by Type (2018-2023) & ($ million)
Table 8. Global Hybrid Closed-Loop lnsulin Delivery System Revenue Market Share by Type (2018-2023)
Table 9. Global Hybrid Closed-Loop lnsulin Delivery System Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Hybrid Closed-Loop lnsulin Delivery System Sales by Application (2018-2023) & (K Units)
Table 11. Global Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Application (2018-2023)
Table 12. Global Hybrid Closed-Loop lnsulin Delivery System Revenue by Application (2018-2023)
Table 13. Global Hybrid Closed-Loop lnsulin Delivery System Revenue Market Share by Application (2018-2023)
Table 14. Global Hybrid Closed-Loop lnsulin Delivery System Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Hybrid Closed-Loop lnsulin Delivery System Sales by Company (2018-2023) & (K Units)
Table 16. Global Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Company (2018-2023)
Table 17. Global Hybrid Closed-Loop lnsulin Delivery System Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Hybrid Closed-Loop lnsulin Delivery System Revenue Market Share by Company (2018-2023)
Table 19. Global Hybrid Closed-Loop lnsulin Delivery System Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Hybrid Closed-Loop lnsulin Delivery System Producing Area Distribution and Sales Area
Table 21. Players Hybrid Closed-Loop lnsulin Delivery System Products Offered
Table 22. Hybrid Closed-Loop lnsulin Delivery System Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Hybrid Closed-Loop lnsulin Delivery System Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Hybrid Closed-Loop lnsulin Delivery System Sales Market Share Geographic Region (2018-2023)
Table 27. Global Hybrid Closed-Loop lnsulin Delivery System Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Hybrid Closed-Loop lnsulin Delivery System Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Hybrid Closed-Loop lnsulin Delivery System Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Country/Region (2018-2023)
Table 31. Global Hybrid Closed-Loop lnsulin Delivery System Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Hybrid Closed-Loop lnsulin Delivery System Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Hybrid Closed-Loop lnsulin Delivery System Sales by Country (2018-2023) & (K Units)
Table 34. Americas Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Country (2018-2023)
Table 35. Americas Hybrid Closed-Loop lnsulin Delivery System Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Hybrid Closed-Loop lnsulin Delivery System Revenue Market Share by Country (2018-2023)
Table 37. Americas Hybrid Closed-Loop lnsulin Delivery System Sales by Type (2018-2023) & (K Units)
Table 38. Americas Hybrid Closed-Loop lnsulin Delivery System Sales by Application (2018-2023) & (K Units)
Table 39. APAC Hybrid Closed-Loop lnsulin Delivery System Sales by Region (2018-2023) & (K Units)
Table 40. APAC Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Region (2018-2023)
Table 41. APAC Hybrid Closed-Loop lnsulin Delivery System Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Hybrid Closed-Loop lnsulin Delivery System Revenue Market Share by Region (2018-2023)
Table 43. APAC Hybrid Closed-Loop lnsulin Delivery System Sales by Type (2018-2023) & (K Units)
Table 44. APAC Hybrid Closed-Loop lnsulin Delivery System Sales by Application (2018-2023) & (K Units)
Table 45. Europe Hybrid Closed-Loop lnsulin Delivery System Sales by Country (2018-2023) & (K Units)
Table 46. Europe Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Country (2018-2023)
Table 47. Europe Hybrid Closed-Loop lnsulin Delivery System Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Hybrid Closed-Loop lnsulin Delivery System Revenue Market Share by Country (2018-2023)
Table 49. Europe Hybrid Closed-Loop lnsulin Delivery System Sales by Type (2018-2023) & (K Units)
Table 50. Europe Hybrid Closed-Loop lnsulin Delivery System Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Hybrid Closed-Loop lnsulin Delivery System Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Hybrid Closed-Loop lnsulin Delivery System Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Hybrid Closed-Loop lnsulin Delivery System Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Hybrid Closed-Loop lnsulin Delivery System Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Hybrid Closed-Loop lnsulin Delivery System Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Hybrid Closed-Loop lnsulin Delivery System
Table 58. Key Market Challenges & Risks of Hybrid Closed-Loop lnsulin Delivery System
Table 59. Key Industry Trends of Hybrid Closed-Loop lnsulin Delivery System
Table 60. Hybrid Closed-Loop lnsulin Delivery System Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Hybrid Closed-Loop lnsulin Delivery System Distributors List
Table 63. Hybrid Closed-Loop lnsulin Delivery System Customer List
Table 64. Global Hybrid Closed-Loop lnsulin Delivery System Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Hybrid Closed-Loop lnsulin Delivery System Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Hybrid Closed-Loop lnsulin Delivery System Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Hybrid Closed-Loop lnsulin Delivery System Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Hybrid Closed-Loop lnsulin Delivery System Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Hybrid Closed-Loop lnsulin Delivery System Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Hybrid Closed-Loop lnsulin Delivery System Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Hybrid Closed-Loop lnsulin Delivery System Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Hybrid Closed-Loop lnsulin Delivery System Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Hybrid Closed-Loop lnsulin Delivery System Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Hybrid Closed-Loop lnsulin Delivery System Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Hybrid Closed-Loop lnsulin Delivery System Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Hybrid Closed-Loop lnsulin Delivery System Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Hybrid Closed-Loop lnsulin Delivery System Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Medtronic Inc. Basic Information, Hybrid Closed-Loop lnsulin Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 79. Medtronic Inc. Hybrid Closed-Loop lnsulin Delivery System Product Portfolios and Specifications
Table 80. Medtronic Inc. Hybrid Closed-Loop lnsulin Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Medtronic Inc. Main Business
Table 82. Medtronic Inc. Latest Developments
Table 83. Insulet Corporation Basic Information, Hybrid Closed-Loop lnsulin Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 84. Insulet Corporation Hybrid Closed-Loop lnsulin Delivery System Product Portfolios and Specifications
Table 85. Insulet Corporation Hybrid Closed-Loop lnsulin Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Insulet Corporation Main Business
Table 87. Insulet Corporation Latest Developments
Table 88. Beta Bionics Basic Information, Hybrid Closed-Loop lnsulin Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 89. Beta Bionics Hybrid Closed-Loop lnsulin Delivery System Product Portfolios and Specifications
Table 90. Beta Bionics Hybrid Closed-Loop lnsulin Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Beta Bionics Main Business
Table 92. Beta Bionics Latest Developments
Table 93. EliLilly Basic Information, Hybrid Closed-Loop lnsulin Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 94. EliLilly Hybrid Closed-Loop lnsulin Delivery System Product Portfolios and Specifications
Table 95. EliLilly Hybrid Closed-Loop lnsulin Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. EliLilly Main Business
Table 97. EliLilly Latest Developments
Table 98. WaveForm (AgaMatrix) Basic Information, Hybrid Closed-Loop lnsulin Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 99. WaveForm (AgaMatrix) Hybrid Closed-Loop lnsulin Delivery System Product Portfolios and Specifications
Table 100. WaveForm (AgaMatrix) Hybrid Closed-Loop lnsulin Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. WaveForm (AgaMatrix) Main Business
Table 102. WaveForm (AgaMatrix) Latest Developments
Table 103. Bigfoot Biomedical Basic Information, Hybrid Closed-Loop lnsulin Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 104. Bigfoot Biomedical Hybrid Closed-Loop lnsulin Delivery System Product Portfolios and Specifications
Table 105. Bigfoot Biomedical Hybrid Closed-Loop lnsulin Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Bigfoot Biomedical Main Business
Table 107. Bigfoot Biomedical Latest Developments
Table 108. Tandem Inc. Basic Information, Hybrid Closed-Loop lnsulin Delivery System Manufacturing Base, Sales Area and Its Competitors
Table 109. Tandem Inc. Hybrid Closed-Loop lnsulin Delivery System Product Portfolios and Specifications
Table 110. Tandem Inc. Hybrid Closed-Loop lnsulin Delivery System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Tandem Inc. Main Business
Table 112. Tandem Inc. Latest Developments
List of Figures
Figure 1. Picture of Hybrid Closed-Loop lnsulin Delivery System
Figure 2. Hybrid Closed-Loop lnsulin Delivery System Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hybrid Closed-Loop lnsulin Delivery System Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Hybrid Closed-Loop lnsulin Delivery System Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Hybrid Closed-Loop lnsulin Delivery System Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Type 1 Hybrid Closed Loop System
Figure 10. Product Picture of Type 2 Hybrid Closed Loop System
Figure 11. Global Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Type in 2022
Figure 12. Global Hybrid Closed-Loop lnsulin Delivery System Revenue Market Share by Type (2018-2023)
Figure 13. Hybrid Closed-Loop lnsulin Delivery System Consumed in Hospital
Figure 14. Global Hybrid Closed-Loop lnsulin Delivery System Market: Hospital (2018-2023) & (K Units)
Figure 15. Hybrid Closed-Loop lnsulin Delivery System Consumed in Private
Figure 16. Global Hybrid Closed-Loop lnsulin Delivery System Market: Private (2018-2023) & (K Units)
Figure 17. Hybrid Closed-Loop lnsulin Delivery System Consumed in Others
Figure 18. Global Hybrid Closed-Loop lnsulin Delivery System Market: Others (2018-2023) & (K Units)
Figure 19. Global Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Application (2022)
Figure 20. Global Hybrid Closed-Loop lnsulin Delivery System Revenue Market Share by Application in 2022
Figure 21. Hybrid Closed-Loop lnsulin Delivery System Sales Market by Company in 2022 (K Units)
Figure 22. Global Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Company in 2022
Figure 23. Hybrid Closed-Loop lnsulin Delivery System Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Hybrid Closed-Loop lnsulin Delivery System Revenue Market Share by Company in 2022
Figure 25. Global Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Hybrid Closed-Loop lnsulin Delivery System Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Hybrid Closed-Loop lnsulin Delivery System Sales 2018-2023 (K Units)
Figure 28. Americas Hybrid Closed-Loop lnsulin Delivery System Revenue 2018-2023 ($ Millions)
Figure 29. APAC Hybrid Closed-Loop lnsulin Delivery System Sales 2018-2023 (K Units)
Figure 30. APAC Hybrid Closed-Loop lnsulin Delivery System Revenue 2018-2023 ($ Millions)
Figure 31. Europe Hybrid Closed-Loop lnsulin Delivery System Sales 2018-2023 (K Units)
Figure 32. Europe Hybrid Closed-Loop lnsulin Delivery System Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Hybrid Closed-Loop lnsulin Delivery System Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Hybrid Closed-Loop lnsulin Delivery System Revenue 2018-2023 ($ Millions)
Figure 35. Americas Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Country in 2022
Figure 36. Americas Hybrid Closed-Loop lnsulin Delivery System Revenue Market Share by Country in 2022
Figure 37. Americas Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Type (2018-2023)
Figure 38. Americas Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Application (2018-2023)
Figure 39. United States Hybrid Closed-Loop lnsulin Delivery System Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Hybrid Closed-Loop lnsulin Delivery System Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Hybrid Closed-Loop lnsulin Delivery System Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Hybrid Closed-Loop lnsulin Delivery System Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Region in 2022
Figure 44. APAC Hybrid Closed-Loop lnsulin Delivery System Revenue Market Share by Regions in 2022
Figure 45. APAC Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Type (2018-2023)
Figure 46. APAC Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Application (2018-2023)
Figure 47. China Hybrid Closed-Loop lnsulin Delivery System Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Hybrid Closed-Loop lnsulin Delivery System Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Hybrid Closed-Loop lnsulin Delivery System Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Hybrid Closed-Loop lnsulin Delivery System Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Hybrid Closed-Loop lnsulin Delivery System Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Hybrid Closed-Loop lnsulin Delivery System Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Hybrid Closed-Loop lnsulin Delivery System Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Country in 2022
Figure 55. Europe Hybrid Closed-Loop lnsulin Delivery System Revenue Market Share by Country in 2022
Figure 56. Europe Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Type (2018-2023)
Figure 57. Europe Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Application (2018-2023)
Figure 58. Germany Hybrid Closed-Loop lnsulin Delivery System Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Hybrid Closed-Loop lnsulin Delivery System Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Hybrid Closed-Loop lnsulin Delivery System Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Hybrid Closed-Loop lnsulin Delivery System Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Hybrid Closed-Loop lnsulin Delivery System Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Hybrid Closed-Loop lnsulin Delivery System Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Hybrid Closed-Loop lnsulin Delivery System Sales Market Share by Application (2018-2023)
Figure 67. Egypt Hybrid Closed-Loop lnsulin Delivery System Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Hybrid Closed-Loop lnsulin Delivery System Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Hybrid Closed-Loop lnsulin Delivery System Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Hybrid Closed-Loop lnsulin Delivery System Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Hybrid Closed-Loop lnsulin Delivery System Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Hybrid Closed-Loop lnsulin Delivery System in 2022
Figure 73. Manufacturing Process Analysis of Hybrid Closed-Loop lnsulin Delivery System
Figure 74. Industry Chain Structure of Hybrid Closed-Loop lnsulin Delivery System
Figure 75. Channels of Distribution
Figure 76. Global Hybrid Closed-Loop lnsulin Delivery System Sales Market Forecast by Region (2024-2029)
Figure 77. Global Hybrid Closed-Loop lnsulin Delivery System Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Hybrid Closed-Loop lnsulin Delivery System Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Hybrid Closed-Loop lnsulin Delivery System Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Hybrid Closed-Loop lnsulin Delivery System Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Hybrid Closed-Loop lnsulin Delivery System Revenue Market Share Forecast by Application (2024-2029)

※参考情報 ハイブリッド閉ループインスリン送達システムは、糖尿病患者にとって重要な革新技術の一つであり、インスリン療法の効率を大幅に向上させることを目的としています。このシステムは、血糖値をリアルタイムで測定し、その結果に基づいて自動的にインスリンを供給するという特徴を持ちます。 この技術の定義として、ハイブリッド閉ループインスリン送達システムは、持続的血糖モニタリング（CGM）技術とインスリンポンプを組み合わせ、血糖値の変動に応じてインスリンの供給を調整する装置として位置付けられます。従来のインスリン療法では、患者が自己判断でインスリンを投与する必要がありますが、このシステムでは、一定の枠組みの中で自動的にインスリンの量を調整することが可能です。 特徴として、まず第一に、リアルタイムでの血糖値モニタリングが挙げられます。CGMセンサーが皮下に挿入され、血糖値の変動を継続的に測定します。次に、インスリンポンプが装着されており、必要に応じてインスリンの供給を行います。これにより、患者が手動でインスリンを注射する手間を省き、より安定した血糖コントロールが実現できます。また、糖尿病患者の個々の生活スタイルや食事パターンを考慮したインスリンの供給調整が可能であり、患者のQOL（Quality of Life）を向上させる要因となっています。 ハイブリッド閉ループシステムにはいくつかの種類があります。一般的には、インスリンの供給を自動的に調整するフルオートマティック型、使用者が一部手動で調整するハイブリッド型があります。フルオートマティック型は、ユーザーがまったく介入しなくても自動で血糖値を管理することができますが、ハイブリッド型では一部手動の操作が必要です。そのため、ユーザーは自分の体調に応じたインスリンの追加投与などを行う必要があります。 用途としては、主に1型糖尿病患者に用いられることが多いですが、最近では2型糖尿病患者にも適用されるケースが増えています。ハイブリッド閉ループシステムは、特に血糖コントロールが難しい患者や、日常的に忙しい環境にいる患者にとって大きな利点をもたらします。これにより、インスリンの過剰投与や不足による血糖の変動を抑えることが可能となり、長期的な合併症のリスクを軽減することができます。 関連技術としては、まずCGM技術が挙げられます。持続的血糖モニタリング装置は、センサーを通じて血糖値をリアルタイムで測定し、データをスマートフォンやタブレットに転送することが可能です。これにより、患者は自分の血糖値を常に把握しやすくなります。また、アルゴリズム技術も重要な要素です。これらのアルゴリズムは、血糖値の変化を予測し、適切なインスリン供給量を計算する役割を果たします。さらに、これらの技術は、機械学習やAI（人工知能）の進展によってますます洗練され、患者の状況に即した最適なインスリン投与を実現しています。 加えて、スマートフォンアプリやクラウドサービスとの統合も進んでおり、患者はデータを簡単に管理し、医療従事者と共有することができます。このような情報の可視化は、患者自身の健康管理を強化し、より良い治療結果につながることが期待されます。 総じて、ハイブリッド閉ループインスリン送達システムは、糖尿病管理の新たなパラダイムを提供するものであり、今後も技術の進化が期待されます。このシステムは、患者の血糖コントロールの安定化のみならず、薬剤費用の削減、生活の質の向上など、多くの利点をもたらすでしょう。患者にとっては、より自分らしい生活を可能にする一助となることが期待されるため、今後の進展に注目が集まります。デジタルヘルスの進化は、ますます糖尿病管理において重要な役割を果たすでしょう。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer